MacroGenics reported $10.42M in Trade Debtors for its fiscal quarter ending in March of 2026.





Trade Debtors Change Date
AbbVie USD 12.59B 180M Dec/2025
Amgen USD 9.14B 432M Mar/2026
AstraZeneca USD 17.88B 1.17B Mar/2026
Biogen USD 1.79B 76.6M Mar/2026
Bristol-Myers Squibb USD 14.36B 164M Mar/2026
Daiichi Sankyo JPY 695.95B 79.1B Dec/2025
Eli Lilly USD 21.18B 1.02B Mar/2026
Genmab DKK 1.17B 119M Dec/2025
Geron USD 39.23M 1.57M Dec/2025
Gilead Sciences USD 4.74B 172M Mar/2026
J&J USD 22.54B 1.21B Mar/2026
Karyopharm Therapeutics USD 26.18M 5.6M Dec/2025
MacroGenics USD 10.42M 2.95M Mar/2026
Merck USD 11.78B 345M Dec/2025
Pfizer USD 16.17B 332M Mar/2026
Puma Biotechnology USD 28.1M 3.52M Jun/2024
Regeneron Pharmaceuticals USD 5.73B 10.1M Mar/2026
Roche Holding CHF 11.9B 460M Dec/2025
Xencor USD 12M 17.3M Mar/2026